Letter: Antilipolytic therapy and the respiratory-distress syndrome.
D000273:Adipose Tissue / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000009:adverse effects / Q000097:blood / Q000378:metabolism; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000627:therapeutic use*; D008168:Lung / Q000378:metabolism; D009748:Nutrition Disorders / Q000150:complications; D010288:Parenteral Nutrition; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D005947:Glucose